Jacqui Oates

1.4k total citations
11 papers, 1.1k citations indexed

About

Jacqui Oates is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacqui Oates has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacqui Oates's work include Colorectal Cancer Treatments and Studies (6 papers), Colorectal and Anal Carcinomas (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). Jacqui Oates is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Colorectal and Anal Carcinomas (5 papers) and Colorectal Cancer Surgical Treatments (4 papers). Jacqui Oates collaborates with scholars based in United Kingdom, Sweden and Spain. Jacqui Oates's co-authors include David Cunningham, Ian Chau, Paul J. Ross, Andy Norman, Justin S. Waters, Gina Brown, Diana Tait, Andrew Wotherspoon, Niall C. Tebbutt and Yu Jo Chua and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Jacqui Oates

11 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqui Oates United Kingdom 10 773 550 464 129 100 11 1.1k
Francesca Di Fabio Italy 18 791 1.0× 421 0.8× 742 1.6× 202 1.6× 152 1.5× 64 1.3k
Hironaga Satake Japan 18 667 0.9× 372 0.7× 573 1.2× 59 0.5× 108 1.1× 147 1.1k
Luca Turati Italy 9 851 1.1× 493 0.9× 441 1.0× 60 0.5× 86 0.9× 18 1.2k
Akio Shiomi Japan 24 1.5k 2.0× 1.2k 2.2× 443 1.0× 87 0.7× 34 0.3× 123 1.8k
María José Safont Spain 16 865 1.1× 488 0.9× 325 0.7× 34 0.3× 39 0.4× 61 1.0k
Günther Klautke Germany 19 605 0.8× 456 0.8× 467 1.0× 71 0.6× 61 0.6× 69 1.0k
Domenico Corsi Italy 13 936 1.2× 568 1.0× 258 0.6× 54 0.4× 20 0.2× 58 1.1k
Mustapha Tehfé Canada 17 699 0.9× 241 0.4× 656 1.4× 43 0.3× 138 1.4× 90 1.1k
Hirotoshi Kobayashi Japan 21 1.6k 2.1× 1.2k 2.2× 711 1.5× 60 0.5× 26 0.3× 94 1.9k
Georg Martin Haag Germany 17 414 0.5× 456 0.8× 634 1.4× 75 0.6× 247 2.5× 60 1.0k

Countries citing papers authored by Jacqui Oates

Since Specialization
Citations

This map shows the geographic impact of Jacqui Oates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqui Oates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqui Oates more than expected).

Fields of papers citing papers by Jacqui Oates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqui Oates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqui Oates. The network helps show where Jacqui Oates may publish in the future.

Co-authorship network of co-authors of Jacqui Oates

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqui Oates. A scholar is included among the top collaborators of Jacqui Oates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqui Oates. Jacqui Oates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sclafani, Francesco, Sanna Hulkki Wilson, David Cunningham, et al.. (2019). Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. International Journal of Cancer. 146(1). 94–102. 39 indexed citations
2.
Sclafani, Francesco, Gina Brown, David Cunningham, et al.. (2017). Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. British Journal of Cancer. 117(10). 1478–1485. 129 indexed citations
3.
Khan, Khurum, David Cunningham, Clare Peckitt, et al.. (2016). miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial. Oncotarget. 7(11). 12672–12681. 35 indexed citations
4.
Chua, Yu Jo, Yolanda Barbáchano, David Cunningham, et al.. (2010). Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. The Lancet Oncology. 11(3). 241–248. 233 indexed citations
5.
Starling, Naureen, David Watkins, David Cunningham, et al.. (2009). Dose Finding and Early Efficacy Study of Gemcitabine Plus Capecitabine in Combination With Bevacizumab Plus Erlotinib in Advanced Pancreatic Cancer. Journal of Clinical Oncology. 27(33). 5499–5505. 18 indexed citations
6.
Sirohi, Bhawna, David Cunningham, Andy Norman, et al.. (2007). Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL). Hematology. 12(2). 149–153. 13 indexed citations
7.
Ross, Paul J., et al.. (2004). Sixty-day all-cause mortality rates in patients treated for gastrointestinal cancers, in randomised trials, at the Royal Marsden Hospital. European Journal of Cancer. 40(15). 2230–2236. 7 indexed citations
8.
Price, Timothy, Paul J. Ross, Tamas Hickish, et al.. (2004). Phase III Study of Mitomycin-C with Protracted Venous Infusion or Circadian-Timed Infusion of 5-Fluorouracil in Advanced Colorectal Carcinoma. Clinical Colorectal Cancer. 3(4). 235–242. 29 indexed citations
9.
Lal, Rohit, David Cunningham, Ian Chau, et al.. (2004). A Randomized Trial Comparing Defined-Duration With Continuous Irinotecan Until Disease Progression in Fluoropyrimidine and Thymidylate Synthase Inhibitor—Resistant Advanced Colorectal Cancer. Journal of Clinical Oncology. 22(15). 3023–3031. 41 indexed citations
10.
11.
Chau, Ian, Mark Allen, David Cunningham, et al.. (2004). The Value of Routine Serum Carcino-Embryonic Antigen Measurement and Computed Tomography in the Surveillance of Patients After Adjuvant Chemotherapy for Colorectal Cancer. Journal of Clinical Oncology. 22(8). 1420–1429. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026